Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	21.48	37.47	30.85
Graham Fair Price	-12.93	7.47	8.58
PEG	104.12	-0.24	0.12
Price/Book	-1.48	28.10	28.52
Price/Cash Flow	35.74	37.77	27.83
Prices/Earnings	31.80	8.76	6.65
Price/Sales	16.12	10.42	8.97
Price/FCF	35.74	37.77	27.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.34	0.51	0.52
Operating Margin	-6.99	0.38	0.41
ROA	-22.12	0.04	0.05
ROE	1.07	0.80	-25.25
ROIC	0.05	0.05	2.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-156.10
Dividends QOQ	< 0.005	< 0.005	200.42
EBIT QOQ	0.11	-0.21	79.47
EPS QOQ	0.57	-0.37	-35.43
FCF QOQ	0.37	-0.27	-26.47
Revenue QOQ	0.26	-0.15	-44.49
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	9.85	10.62	7.74
Days Sales Outstanding (DSO)	21.81	15.57	-28.63
Inventory Turnover	9.13	8.48	-7.18
Debt/Capitalization	0.95	0.95	-0.08
Quick Ratio	0.78	0.25	-68.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.75	1.76	0.71
Cash	1.19	0.69	-42.09
Capex	-0.10	-0.07	28.00
Free Cash Flow	1.79	1.31	-26.91
Revenue	5.55	4.74	-14.56
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.01	0.37	-62.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.03	14.74	22.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating